New Program Offers Enhanced Support to Maximize the Benefits of MyoPro® to Direct Clients
CAMBRIDGE, Mass. (July 9, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the launch of MyoCare™, a new program that provides enhanced support to first-year users of the Company’s MyoPro® powered brace in order to maximize the benefits they receive from the device. Read more.